Bristol-Myers Squibb Company (BMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
03-1997 | 12-1996 | 09-1996 | 06-1996 | 03-1996 | |
Sales | 4,045,000 | 3,955,000 | 3,745,000 | 3,696,000 | 3,669,000 |
Cost of Goods | 1,078,000 | 1,065,000 | 1,003,000 | 962,000 | 935,000 |
Gross Profit | 2,967,000 | 2,890,000 | 2,742,000 | 2,734,000 | 2,734,000 |
Operating Expenses | 1,834,000 | 1,942,000 | 1,682,000 | 1,811,000 | 1,712,000 |
Operating Income | 1,133,000 | 948,000 | 1,060,000 | 923,000 | 1,022,000 |
Other Income | 0 | 60,000 | 0 | 0 | 0 |
Pre-tax Income | 1,133,000 | 1,008,000 | 1,060,000 | 923,000 | 1,022,000 |
Income Tax | 323,000 | 292,000 | 307,000 | 268,000 | 296,000 |
Net Income Continuous | 810,000 | 716,000 | 753,000 | 655,000 | 726,000 |
Net Income | $810,000 | $716,000 | $753,000 | $655,000 | $726,000 |
EPS Basic Total Ops | 0.41 | 0.36 | 0.38 | 0.33 | 0.36 |
EPS Basic Continuous Ops | 0.41 | 0.36 | 0.38 | 0.33 | 0.36 |
EPS Diluted Total Ops | 0.41 | 0.36 | 0.38 | 0.33 | 0.36 |
EPS Diluted Continuous Ops | 0.41 | 0.36 | 0.38 | 0.33 | 0.36 |
EBITDA(a) | $1,267,000 | $1,087,000 | $1,186,000 | $1,046,000 | $1,153,000 |